Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-30

Clinical Trial Update: Efficacy of Lactobacillus Rhamnosus LRa05 in Gestational Diabetes [NA]

View source ↗

Summary

Clinical trial evaluating the efficacy of the probiotic Lactobacillus rhamnosus LRa05 in gestational diabetes mellitus. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus rhamnosus LRa05 (Lactobacillus rhamnosus LRa05)

Snippet

Sponsor: Wecare Probiotics Co., Ltd. | Conditions: GDM | NA | Status: RECRUITING